4//SEC Filing
Carmer Scott 4
Accession 0001209191-21-012357
CIK 0001538210other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:22 PM ET
Size
7.2 KB
Accession
0001209191-21-012357
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Carmer Scott
DirectorPresident and CEO
Transactions
- Conversion
Common Stock
2021-02-17+7,058→ 7,058 total - Conversion
Series A Preferred Stock
2021-02-17−7,058→ 0 total→ Common Stock (7,058 underlying)
Footnotes (3)
- [F1]The shares of preferred stock automatically converted into common stock immediately upon completion of the Issuer's initial public offering on a 1-for-1 basis.
- [F2]The shares of preferred stock were convertible into the Issuer's common stock in accordance with the Issuer's Restated Certificate of Incorporation, as amended, immediately upon completion of the Issuer's initial public offering.
- [F3]Not applicable.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001843694
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:22 PM ET
- Size
- 7.2 KB